2023. Levosimendan off-label successfully used in two patients with exacerbated COPD and severe bronchospasm: a case series focusing on an explorative review of the current literature. Advances in Anesthesia and Pain Medicine. 1, 1 (Nov. 2023). DOI:https://doi.org/10.4081/amsa.2023.36.